December 29, 2023 · Form 4 insider transaction
Goldberg Mark Alan bought 569 shares of ImmunoGen, Inc. at $29.65 per share, a transaction worth $16.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Shares of common stock issued pursuant to the Compensation Policy for Non-Employee Directors as amended June 14, 2023 in lieu of cash compensation for services performed for the quarter ended December 31, 2023.